Models for sexually transmitted infections

Q3 Pharmacology, Toxicology and Pharmaceutics
Katja Knapp, Georg Stary
{"title":"Models for sexually transmitted infections","authors":"Katja Knapp,&nbsp;Georg Stary","doi":"10.1016/j.ddmod.2020.11.003","DOIUrl":null,"url":null,"abstract":"<div><p><span><span><span>Extensive research on sexually transmitted infections (STI) in the last century has led to a better understanding of disease prevention and treatment options. Nowadays, bacterial infections with chlamydia<span>, gonorrhea or </span></span>syphilis<span> are curable with antibiotics. Also, infection with HIV has lost its terror as there exists a treatment allowing patients a normal life. Pre- and post-exposure prophylaxis of HIV with anti-retroviral drugs prevents infection of sexual partners. However, health organizations report that STI are on the rise again, being problematic as many infections remain undetected, thereby causing cancers, infertility or </span></span>congenital infection<span>. To circumvent this, development of vaccines against different STI are urgently needed. As it is difficult to study interaction between host and pathogen in humans, model systems including animal models and </span></span><em>in vitro</em> approaches are necessary. Within this review, we give an overview on animal models of STI with a focus on chlamydia infection, discussing advantages and disadvantages of modeling infection with species-specific or human pathogens. Moreover, we present available <em>in vitro</em> models of STI, pointing out current advances in the development of three-dimensional (3D) culture systems closely resembling human tissue architecture. This allows to explore infection under physiological conditions in human cells without ethical concerns. A toolbox full of tightly coordinated <em>in vivo</em> and <em>in vitro</em> infection models will be required to advance STI research and vaccine design in the future.</p></div>","PeriodicalId":39774,"journal":{"name":"Drug Discovery Today: Disease Models","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today: Disease Models","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1740675720300116","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Extensive research on sexually transmitted infections (STI) in the last century has led to a better understanding of disease prevention and treatment options. Nowadays, bacterial infections with chlamydia, gonorrhea or syphilis are curable with antibiotics. Also, infection with HIV has lost its terror as there exists a treatment allowing patients a normal life. Pre- and post-exposure prophylaxis of HIV with anti-retroviral drugs prevents infection of sexual partners. However, health organizations report that STI are on the rise again, being problematic as many infections remain undetected, thereby causing cancers, infertility or congenital infection. To circumvent this, development of vaccines against different STI are urgently needed. As it is difficult to study interaction between host and pathogen in humans, model systems including animal models and in vitro approaches are necessary. Within this review, we give an overview on animal models of STI with a focus on chlamydia infection, discussing advantages and disadvantages of modeling infection with species-specific or human pathogens. Moreover, we present available in vitro models of STI, pointing out current advances in the development of three-dimensional (3D) culture systems closely resembling human tissue architecture. This allows to explore infection under physiological conditions in human cells without ethical concerns. A toolbox full of tightly coordinated in vivo and in vitro infection models will be required to advance STI research and vaccine design in the future.

性传播感染模型
上个世纪对性传播感染(STI)的广泛研究使人们更好地了解疾病的预防和治疗方案。如今,衣原体、淋病或梅毒等细菌感染都可以用抗生素治愈。另外,艾滋病病毒感染也不再可怕,因为有一种治疗方法可以让患者过上正常的生活。使用抗逆转录病毒药物进行艾滋病毒暴露前和暴露后预防,可防止性伴侣感染。然而,卫生组织报告说,性传播感染再次上升,这是一个问题,因为许多感染未被发现,从而导致癌症、不孕症或先天性感染。为了避免这种情况,迫切需要开发针对不同性传播感染的疫苗。由于宿主与病原体在人体中的相互作用难以研究,因此需要包括动物模型和体外方法在内的模型系统。在这篇综述中,我们概述了性传播感染的动物模型,重点是衣原体感染,讨论了用物种特异性或人类病原体建模感染的优点和缺点。此外,我们提出了可用的STI体外模型,指出了目前在开发与人体组织结构非常相似的三维(3D)培养系统方面的进展。这使得在没有伦理问题的情况下探索人体细胞生理条件下的感染。今后将需要一个充满紧密协调的体内和体外感染模型的工具箱来推进性传播感染研究和疫苗设计。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Discovery Today: Disease Models
Drug Discovery Today: Disease Models Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
自引率
0.00%
发文量
0
期刊介绍: Drug Discovery Today: Disease Models discusses the non-human experimental models through which inference is drawn regarding the molecular aetiology and pathogenesis of human disease. It provides critical analysis and evaluation of which models can genuinely inform the research community about the direct process of human disease, those which may have value in basic toxicology, and those which are simply designed for effective expression and raw characterisation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信